ReCreate Foundation Porcelain

Dosage form: cream
Ingredients: Octinoxate 2.2125mL in 29.5mL, Octisalate 1.18mL in 29.5mL, Oxybenzone .59mL in 29.5mL
Labeler: Tarte Inc
NDC Code: 51060-001

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

ReCreate™
foundation with
Wrinkle Rewind™ technology

Drug Facts

Active ingredientsPurpose
Octinoxate 7.5%Sunscreen
Octisalate 4.0%Sunscreen
Oxybenzone 2.0%Sunscreen

Uses
  • helps prevent sunburn.
  • higher SPF gives more sun protection.

Warnings

For external use only.

When using this product keep out of eyes. Rinse with water to remove.

Stop use and ask doctor if rash or irritation develops and lasts.

Keep out of the reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions
  • Apply evenly over entire face. Apply liberally before sun exposure and as needed.
  • Children under 6 months of age: ask a doctor.

Other information

You may report a serious adverse reaction to: tarte, Inc. 53 W 36th Street Suite 902 New York, NY 10018.

Inactive ingredients

water, cyclopentasiloxane, cetyl, PEG/PPG-10/1 dimethicone, butylene glycol, cyclohexasiloxane, ozkerite, silica, VP/elcosene copolymer, disteardimonium hectorite, magnesium sulfate, polyglyceryl-4-isostearate, hexyl laurate, bis-vinyl dimethicone, dimethicone copolymer, phenoxyethanol, acrylates, polytrimethysloxymethacrylate copolymer, beeswax, potassium sorbate, glycereth-18 ethylhexacanoate, boron nitride, polymethylsilsesquioxane, C18-21 alkaine, polyisobutene, ethoxydiglycol, xanthan gum, barium sulfate, C30-45 alkyl cetearyl dimethicone crosspolymer, caprylyl glycol, 1,2-hexanediol, glycereth-18, isododecane, triethoxycaprylylsilane, aluminum dimyrustate, hydrolyzed vegetable protein, propylene carbonate, allantoin, disodium stearoyl glutamate, trehalose, glycerin, hexyfene glycol, gold, peat extract, palmitoyl hexapeptide-14, sodium benzoate, sodium hyaluronate, (+/-); Mica, iron oxides, titanium dioxide.

PRINCIPAL DISPLAY PANEL - 29.5 mL Carton

NEW
FLO-THRU™
pump

tarte™

high-performance naturals™

ReCreate™

foundation with
Wrinkle Rewind™ technology

SPF 15 UVA/UVB Broad Spectrum
Sunscreen

29.5 mL e 1 Fl. Oz.

RECREATE FOUNDATION   PORCELAIN
octinoxate, octisalate, and oxybenzone cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51060-001
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Octinoxate (Octinoxate) Octinoxate2.2125 mL  in 29.5 mL
Octisalate (Octisalate) Octisalate1.18 mL  in 29.5 mL
Oxybenzone (Oxybenzone) Oxybenzone.59 mL  in 29.5 mL
Product Characteristics
ColorBROWNScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage Description
1NDC:51060-001-291 BOTTLE, PUMP (BOTTLE) in 1 CARTON
129.5 mL in 1 BOTTLE, PUMP
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart35206/01/2010
RECREATE FOUNDATION   IVORY
octinoxate, octisalate, and oxybenzone cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51060-002
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Octinoxate (Octinoxate) Octinoxate2.2125 mL  in 29.5 mL
Octisalate (Octisalate) Octisalate1.18 mL  in 29.5 mL
Oxybenzone (Oxybenzone) Oxybenzone.59 mL  in 29.5 mL
Product Characteristics
ColorBROWNScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage Description
1NDC:51060-002-921 BOTTLE, PUMP (BOTTLE) in 1 CARTON
129.5 mL in 1 BOTTLE, PUMP
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart35206/01/2010
RECREATE FOUNDATION   COOL BISQUE
octinoxate, octisalate, and oxybenzone cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51060-003
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Octinoxate (Octinoxate) Octinoxate2.2125 mL  in 29.5 mL
Octisalate (Octisalate) Octisalate1.18 mL  in 29.5 mL
Oxybenzone (Oxybenzone) Oxybenzone.59 mL  in 29.5 mL
Product Characteristics
ColorBROWNScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage Description
1NDC:51060-003-291 BOTTLE, PUMP (BOTTLE) in 1 CARTON
129.5 mL in 1 BOTTLE, PUMP
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart35206/01/2010
RECREATE FOUNDATION   WARM BISQUE
octinoxate, octisalate, and oxybenzone cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51060-004
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Octinoxate (Octinoxate) Octinoxate2.2125 mL  in 29.5 mL
Octisalate (Octisalate) Octisalate1.18 mL  in 29.5 mL
Oxybenzone (Oxybenzone) Oxybenzone.59 mL  in 29.5 mL
Product Characteristics
ColorBROWNScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage Description
1NDC:51060-004-291 BOTTLE, PUMP (BOTTLE) in 1 CARTON
129.5 mL in 1 BOTTLE, PUMP
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart35206/01/2010
RECREATE FOUNDATION   BEIGE
octinoxate, octisalate, and oxybenzone cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51060-005
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Octinoxate (Octinoxate) Octinoxate2.2125 mL  in 29.5 mL
Octisalate (Octisalate) Octisalate1.18 mL  in 29.5 mL
Oxybenzone (Oxybenzone) Oxybenzone.59 mL  in 29.5 mL
Product Characteristics
ColorBROWNScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage Description
1NDC:51060-005-291 BOTTLE, PUMP (BOTTLE) in 1 CARTON
129.5 mL in 1 BOTTLE, PUMP
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart35206/01/2010
RECREATE FOUNDATION   COOL SAND
octinoxate, octisalate, and oxybenzone cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51060-006
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Octinoxate (Octinoxate) Octinoxate2.2125 mL  in 29.5 mL
Octisalate (Octisalate) Octisalate1.18 mL  in 29.5 mL
Oxybenzone (Oxybenzone) Oxybenzone.59 mL  in 29.5 mL
Product Characteristics
ColorBROWNScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage Description
1NDC:51060-006-291 BOTTLE, PUMP (BOTTLE) in 1 CARTON
129.5 mL in 1 BOTTLE, PUMP
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart35206/01/2010
RECREATE FOUNDATION   WARM SAND
octinoxate, octisalate, and oxybenzone cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51060-007
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Octinoxate (Octinoxate) Octinoxate2.2125 mL  in 29.5 mL
Octisalate (Octisalate) Octisalate1.18 mL  in 29.5 mL
Oxybenzone (Oxybenzone) Oxybenzone.59 mL  in 29.5 mL
Product Characteristics
ColorBROWNScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage Description
1NDC:51060-007-291 BOTTLE, PUMP (BOTTLE) in 1 CARTON
129.5 mL in 1 BOTTLE, PUMP
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart35206/01/2010
RECREATE FOUNDATION   NATURAL
octinoxate, octisalate, and oxybenzone cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51060-008
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Octinoxate (Octinoxate) Octinoxate2.2125 mL  in 29.5 mL
Octisalate (Octisalate) Octisalate1.18 mL  in 29.5 mL
Oxybenzone (Oxybenzone) Oxybenzone.59 mL  in 29.5 mL
Product Characteristics
ColorBROWNScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage Description
1NDC:51060-008-291 BOTTLE, PUMP (BOTTLE) in 1 CARTON
129.5 mL in 1 BOTTLE, PUMP
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart35206/01/2010
RECREATE FOUNDATION   HONEY
octinoxate, octisalate, and oxybenzone cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51060-009
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Octinoxate (Octinoxate) Octinoxate2.2125 mL  in 29.5 mL
Octisalate (Octisalate) Octisalate1.18 mL  in 29.5 mL
Oxybenzone (Oxybenzone) Oxybenzone.59 mL  in 29.5 mL
Product Characteristics
ColorBROWNScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage Description
1NDC:51060-009-291 BOTTLE, PUMP (BOTTLE) in 1 CARTON
129.5 mL in 1 BOTTLE, PUMP
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart35206/01/2010
RECREATE FOUNDATION   WARM WALNUT
octinoxate, octisalate, and oxybenzone cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51060-010
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Octinoxate (Octinoxate) Octinoxate2.2125 mL  in 29.5 mL
Octisalate (Octisalate) Octisalate1.18 mL  in 29.5 mL
Oxybenzone (Oxybenzone) Oxybenzone.59 mL  in 29.5 mL
Product Characteristics
ColorBROWNScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage Description
1NDC:51060-010-291 BOTTLE, PUMP (BOTTLE) in 1 CARTON
129.5 mL in 1 BOTTLE, PUMP
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart35206/01/2010
RECREATE FOUNDATION   WALNUT
octinoxate, octisalate, and oxybenzone cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51060-011
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Octinoxate (Octinoxate) Octinoxate2.2125 mL  in 29.5 mL
Octisalate (Octisalate) Octisalate1.18 mL  in 29.5 mL
Oxybenzone (Oxybenzone) Oxybenzone.59 mL  in 29.5 mL
Product Characteristics
ColorBROWNScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage Description
1NDC:51060-011-291 BOTTLE, PUMP (BOTTLE) in 1 CARTON
129.5 mL in 1 BOTTLE, PUMP
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart35206/01/2010
RECREATE FOUNDATION   CHESTNUT
octinoxate, octisalate, and oxybenzone cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51060-012
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Octinoxate (Octinoxate) Octinoxate2.2125 mL  in 29.5 mL
Octisalate (Octisalate) Octisalate1.18 mL  in 29.5 mL
Oxybenzone (Oxybenzone) Oxybenzone.59 mL  in 29.5 mL
Product Characteristics
ColorBROWNScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage Description
1NDC:51060-012-291 BOTTLE, PUMP (BOTTLE) in 1 CARTON
129.5 mL in 1 BOTTLE, PUMP
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart35206/01/2010
Labeler - Tarte Inc (027905186)

Revised: 04/2010
 
Tarte Inc

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web2)